JG

Jarret Glasscock

Chief Executive Officer at Cofactor Genomics Inc. (RNA Diagnostics Company)

San Francisco Bay Area

Invests in

  • Min Investment:

    $200,000.00
  • Max Investment:

    $300,000.00
  • Target Investment:

    $250,000.00

Education

Work Experience

  • Chief Executive Officer

    2016

SLU

2014

  • Industry Advisory Board Member

    2014

    Board member advising on direction and curriculum of Bioinformatics and Computational Biology Degree Program.

2018 - 2020

  • Senior Venture Partner - Healthcare/Biotech

    2018 - 2020

    Supporting YC founders in the Healthcare/Biotech vertical. Ensuring biotech of tomorrow has the funding it needs today.

Cofactor Genomics, LLC (Pharma Sequencing Services)

2010 - 2015

  • Founder and CEO

    2010 - 2015

    Growing Cofactor Genomics more than 100% each year by building a world class team that can bring RNA-based Discovery and Diagnostics products to market.

Cofactor Genomics LLC, (Pharma Sequencing Services)

2008 - 2010

  • Founder and CTO

    2008 - 2010

    Focused on providing both direction and expertise to Cofactor concerning its goals of visualization and algorithmic approaches necessary to keep pace with its Next Generation Sequencing Services. Specific applications for genomic, miRNA, epigenitic, and transcriptome studies.

  • Research Faculty

    2006 - 2008

    Research Faculty; Dept. of Genetics appointment. Technology Development; Washington University Genome Sequencing Center. Saint Louis, MO Development of methodologies/algorithms in context of new sequencing technologies.

  • Group Leader; Computational Biology Group WU Genome Sequencing Center

    2005 - 2007

    Group Leader directing the center’s comparative genomic analysis efforts

  • Senior Scientist

    2004 - 2005

    Comparitive Genomics on the centers largest projects.

Corvus Research Group

2006 - 2007

  • Principal

    2006 - 2007

    Corvus Research Group is a company of genomic scientists providing custom software solutions to industry and academia partners.